Weight loss drug makers’ stocks get a boost from new Biden coverage proposal, but will it hold up?

Weight-loss-drug makers’ stocks get a boost from new Biden coverage proposal, but will it hold up?

The stocks of companies that make the new class of drugs to treat obesity and manage diabetes were higher across the board early Tuesday, after the Biden administration proposed a rule that would ...

Business - MarketWatch - 23 hours ago

Biden proposes huge expansion of US weight-loss drug coverage

State-backed insurance programmes would fund drugs for obese patients without separate health conditions

World - Financial Times - Yesterday

Biden proposes weight loss drug coverage requirements for Medicare and Medicaid

Weight loss drugs like Wegovy, Zepbound and Ozempic would be covered by Medicare and Medicaid under a Biden administration proposal.

Biden proposes expanded coverage for weight loss drugs under Medicare, Medicaid

The Biden administration has proposed a plan for Medicare and Medicaid to offer coverage for weight loss medications, such as Ozempic and Wegovy.

Politics - NBC News - 18 hours ago

Biden proposes weight loss drug coverage by Medicare, Medicaid

President Biden's proposal for Medicaid and Medicare coverage for weight loss drugs such as Ozempic and Wegovy could draw opposition from the drug industry and President-elect Donald Trump's ...

Why Biden is proposing weight loss drug Medicare, Medicaid coverage

President Biden's proposal to expand Medicaid and Medicare coverage for some weight loss drugs could impact thousands of Americans. CBS News' Alexander Tin breaks down what's known about the ...

Biden’s plan for Medicare coverage of weight-loss drugs would drive up costs by billions of dollars

The plan would need to be supported by the incoming Trump administration, which has vowed to cut costs across the federal government.

Business - MarketWatch - 39 minutes ago

Biden proposes Medicare and Medicaid cover weight-loss drugs for obese Americans

Millions of obese Americans would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by Medicare or Medicaid under a new rule the Biden administration proposed Tuesday ...

Health - ABC News - 16 hours ago

Biden proposes Medicare and Medicaid cover weight-loss drugs for 7.4m people

Move aims to tackle US’s chronic obesity problem, but poses a challenge to Trump’s incoming administration. The Biden administration is proposing to make “miracle” weight loss drugs free for ...

World - The Guardian - 20 hours ago

Biden seeks Medicare and Medicaid coverage of popular but costly weight-loss drugs for millions of Americans

Health - ABC News - Yesterday

Biden proposes Medicare, Medicaid coverage of obesity drugs

The Biden administration proposed a new rule Tuesday that would allow anti-obesity drugs like Wegovy and Zepbound to be covered under Medicaid and Medicare for more Americans. Millions of Americans ...

Politics - The Hill - 19 hours ago

Doctor says Biden's weight-loss drug proposal is a "formal recognition" that obesity is an illness

The Biden administration is proposing a new rule that would make popular weight loss drugs like Ozempic covered by Medicare and Medicaid. CBS News medical contributor Dr. Celine Gounder discusses ...

Employers Get Pressure to Pay for Drugs Like Wegovy

Eli Lilly and Novo Nordisk representatives get face time with companies in hopes they will cover their weight-loss drugs.

Business - The Wall Street Journal - November 19

Biden proposes expanding obesity drug coverage under Medicare and Medicaid

The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans with Medicare and Medicaid.

Viking Therapeutics’ weight-loss pill shows ‘great outcome’ in trial

The stock, which enjoys the unusual position of having all buy ratings from the 13 analysts offering coverage on FactSet, has been on a tear this year, gaining 270% to date in 2024.

Business - MarketWatch - November 4

RFK Jr. is not a fan of weight-loss drugs or vaccines. Stocks are tanking.

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply lower Friday, after President-elect Donald Trump named Robert F. Kennedy ...

Business - MarketWatch - November 16

New Obesity Drug MariTide Helps Patients Lose Up to 20% of Weight, Early Data Shows

The drug, which is named MariTide and delivered in a monthly injection, is some time away from being sold.

Business - The New York Times - 17 hours ago

Amgen says no concerns around weight loss drug’s bone density data after stock falls

Analysts chewed over early data showing the highest dose of Amgen's MariTide was linked to roughly 4% loss of bone mineral density over 12 weeks.

Business - CNBC - November 13

Amgen’s stock closes off lows to avoid worst day in 24 years as weight-loss-drug data underwhelms

Amgen’s MariTide achieved up to 20% weight loss in a mid-stage trial, but analysts were expecting up to 25%.

Business - MarketWatch - 39 minutes ago

Cheap Ozempic? How millions of Americans with obesity may get access to costly weight-loss drugs

Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 billion proposal from the Biden administration is blessed by ...

Health - ABC News - 9 hours ago

Here are 4 biotech stocks that could get a boost from Trump’s new regulatory climate

Biotech-stock investing has one tough test for success — and it’s about to get easier

Business - MarketWatch - 3 days ago

Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau

The results shed light on how MariTide may measure up to weight loss injections from Novo Nordisk and Eli Lilly and other experimental treatments.

Business - CNBC - 16 hours ago

Nurse’s death linked to approved weight-loss drug

Susan McGowan from North Lanarkshire died two weeks after taking the drug tirzepatide, brand name Mounjaro.

New White House rule would make weight loss drugs available for people on Medicare and Medicaid

A New White House proposal would make Medicare and Medicaid cover GLP-1 weight loss drugs for people who are obese. The move would expand affordable access to the drugs to some 7.4 million people. ...

Caregivers’ retirement security — often jeopardized by time away from work — could get a boost from these proposals

“Family members often make tremendous sacrifices to leave the workforce and care for their aging relatives, and as a result, they miss out on key years of saving for their own golden years.”

Business - MarketWatch - November 18

Biden proposes to restrict pollution from new gas plants

The Biden administration has proposed a rule that it says will reduce pollution stemming from new gas-fired power plants and other industrial facilities. The proposal would require these plants to ...

Politics - The Hill - 4 days ago

Biden proposes anti-obesity drug rule

Click in for more news from The Hill {beacon} Health Care Health Care The Big Story Biden proposes Medicaid, Medicare cover obesity drugs A proposed rule from the Biden administration would ...

Politics - The Hill - 14 hours ago

Weight loss drug industry injects wealth into Novo Nordisk home country

Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide— while adding great heft to the economy of Novo Nordisk's home country, Denmark.

Latest in Weight loss drug makers’ stocks get a boost from new Biden coverage proposal, but will it hold up?